These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16553852)

  • 1. Effects of subinhibitory concentrations of clindamycin on the morphological, biochemical and genetic characteristics of Bacteroides fragilis.
    Silvestro EM; Nakano V; Arana-Chavez VE; Marques MV; Avila-Campos MJ
    FEMS Microbiol Lett; 2006 Apr; 257(2):189-94. PubMed ID: 16553852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
    Nakano V; Padilla G; do Valle Marques M; Avila-Campos MJ
    Res Microbiol; 2004 Dec; 155(10):843-6. PubMed ID: 15567279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteroides fragilis response to subinhibitory concentrations of antimicrobials includes different morphological, physiological and virulence patterns after in vitro selection.
    Freitas MC; Silva VL; Gameiro J; Ferreira-Machado AB; Coelho CM; Cara DC; Diniz CG
    Microb Pathog; 2015 Jan; 78():103-13. PubMed ID: 25513969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Production of enterotoxins by Bacteroids fragilis strains--effect of clindamycin].
    Rokosz A; Rouyan GS; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1997; 49(3-4):153-9. PubMed ID: 9554147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteroides fragilis. Its isolation and antibiotic sensitivity].
    Cancet B; Nadaud M
    Ann Biol Clin (Paris); 1976; 34(2):133-7. PubMed ID: 970703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes.
    Löfmark S; Jernberg C; Jansson JK; Edlund C
    J Antimicrob Chemother; 2006 Dec; 58(6):1160-7. PubMed ID: 17046967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
    Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
    Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics of choice against Bacteroides fragilis.
    Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of clindamycin resistance in the Bacteroides fragilis group.
    Reig M; Campello MG; Baquero F
    J Antimicrob Chemother; 1984 Dec; 14(6):595-603. PubMed ID: 6520060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug resistance of bacteria and countermeasures--current status of resistance. 5. Anaerobic bacteria].
    Watanabe K; Ueno K
    Nihon Rinsho; 1986 Apr; 44(4):982-6. PubMed ID: 3761600
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of the LAL test for quantitative determination of Bacteroids fragilis endotoxin].
    Rokosz A; Marciniak-Rusek A; Aleksandrowicz J; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1997; 49(3-4):161-8. PubMed ID: 9554148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
    Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
    Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of clindamycin resistance in Bacteroides species.
    Guiney DG; Hasegawa P; Stalker D; Davis CE
    J Infect Dis; 1983 Mar; 147(3):551-8. PubMed ID: 6833799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
    Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
    J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
    Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
    J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections caused by Bacteroides fragilis resistant to clindamycin: 2 further cases].
    Andrieu J; Kwantes M; Lapeyrere X; Gardon JD
    Nouv Presse Med; 1978 Feb; 7(7):571-2. PubMed ID: 643586
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.
    Klepser ME; Banevicius MA; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1941-4. PubMed ID: 8843310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.